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Summary 
Self-reactive B  cells  from  tolerant  double-transgenic  (Dbl-Tg)  mice  coexpressing hen  egg 
lysozyme (HEL) and rearranged anti-HEL immunoglobulin genes have a relatively short life 
span when compared to normal B cells, irrespective of whether they are exposed to antigen in 
multivalent  membrane-bound  form  (mHEL-Dbl-Tg mice)  or  soluble  form  (sHEL-Dbl-Tg 
mice). The factors responsible for determining the fate of these B  cells after encounter with 
self-antigen were investigated using a cell-tracking technique in which anti-HEL Ig-Tg spleen 
ceils were labeled with the intracellular dye 5-carboxyfluorescein diacetate-succinimidyl ester 
(CFSE) and injected either into non-Tg recipients or a variety of HEL-Tg hosts. In non-Tg re- 
cipients, HEL-binding B cells persisted in the circulation and could be detected in the follicles 
of the spleen for at least 5 d. On transfer into either mHEL-Tg or sHEL-Tg hosts, they under- 
went activation and then rapidly disappeared from the blood and spleen over the next 3 d, con- 
sistent with the short life span reported previously. Immunohistology of spleens from sHEL-Tg 
recipients indicated that the transferred B ceils had migrated to the outer margins of the periar- 
teriolar lymphoid sheath (PALS), where they were detectable for 24 h before being lost. The 
positioning of  B cells in the outer PALS depended on a critical threshold of Ig receptor binding 
corresponding to  a serum  HEL concentration between 0.5  and  15  ng/ml,  but was  not re- 
stricted to endogenously expressed HEL in that the same migratory pattern was observed after 
transfer into non-Tg recipients given exogenous (foreign) HEL. Moreover, bone marrow-derived 
immature Ig-Tg B cells homed to the outer PALS of sHEL-Tg mice and then disappeared at 
the same rate as mature B cells, indicating that the stage of maturation did not influence the fate 
of self-reactive B  cells  in  a tolerant environment.  On the  other hand,  HEL-binding B  cells 
transferred into sHEL-Dbl-Tg recipients persisted over the 3-d period of study, apparently due 
to insufficient availability of antigen,  as indicated by the fact that the  degree of Ig receptor 
downregulation on the transferred B cells was much less than in sHEL-Tg recipients. If T  cell 
help was provided to Ig-Tg B cells at the time of transfer into sHEL-Tg recipients in the form 
of preactivated CD4 + T  cells specific for major histocompatibility complex-peptide complexes 
on the B  cell surface, HEL-binding B cells migrated through the outer PALS of the spleen to 
the follicle, where they formed germinal centers, or to adjacent red pulp, where they formed pro- 
liferative foci and secreted significant amounts of anti-HEL antibody. Taken together, these results 
indicated that the outcome of the interaction between self-antigen and B cells is largely deter- 
mined by a combination of the degree of receptor engagement and availability ofT cell help. 
A 
utoimmune disorders are frequently characterized by the 
presence of autoantibodies. The mechanisms whereby 
B  ceils are normally prevented from producing such anti- 
bodies have been extensively studied in a number of trans- 
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system (4).  In this model, Ig-transgenic (Ig-Tg) mice were 
created in which the great majority of B  cells  express high 
affinity IgM and IgD receptors for HEL. Double-transgenic 
(Dbl-Tg) mice were then produced by crossing Ig-Tg mice 
with a second line of transgenic mice expressing HEL as a 
neo-self antigen  in  soluble  (sHEL-Tg)  (4)  or membrane- 
bound (mHEL-Tg) form (5).  The fate of newly generated 
self-reactive B cells in these mice was shown to be critically 
dependent  on  the  degree  of receptor  engagement  by self 
antigen.  Thus, after exposure to self-antigen in membrane- 
bound form, B cells were deleted in the bone marrow with 
a life span of,'-,15 h  (5,  6). By contrast, B  cells exposed to 
soluble self-antigen in oligovalent form persisted and colo- 
nized the splenic follicles in a tolerant  (anergic)  state  char- 
acterized by downregulation  of surface  IgM, but  not IgD 
(4). Nevertheless, these ceils failed to enter the long-lived B 
cell compartment and had a markedly reduced life span of 
,'~3-5 d compared with 4-5 wk for normal B cells  (7).  This 
reduction  in  life  span  was  a  constant  feature  of tolerant 
(self-reactive)  B  cells  throughout  life,  whereas  the  mean 
half-life  of nontolerant  normal B  cells  increased  with  age, 
presumably because of the ongoing recruitment of cells into 
the long-lived compartment (8). 
The  interpretation  of  these  findings  favored  by  our 
group was  that  the longevity of self-reactive B  cells  is re- 
lated to the degree of receptor engagement by self-antigen 
(8).  Based on a different series of experiments  in the same 
transgenic model, Cyster et al.  (9) have presented an alter- 
native  hypothesis to explain  why self-reactive B  cells  may 
be eliminated on reaching peripheral lymphoid tissue.  This 
states that self-reactive B  ceils are normally excluded from 
primary follicles and die as a result of competition with the 
anti-foreign  (polyclonal)  B  cell  repertoire.  To  distinguish 
between these possibilities, the fate of self reactive B cells in 
vivo was studied in a series of cell-tracking experiments in 
which mature or immature Ig-Tg B cells were labeled with 
the fluorescent dye 5-carboxyfluorescein diacetate-succin- 
imidyl ester (CFSE)  (10) and transferred into transgenic re- 
cipients  expressing HEL as an endogenous  (neo-self)  anti- 
gen or non-Tg recipients in the presence or absence of HEL 
given as an exogenous (foreign) antigen.  The advantage of 
using CFSE is that labeled  cells  can be distinguished  from 
host lymphocytes and that up to five to six cell divisions can 
be  readily  detected  by progressive  twofold  reductions  in 
CFSE intensity. In the absence of antigen, the Ig-Tg B cells 
populated the follicles ofnon-Tg hosts, but on transfer into 
Tg  recipients  expressing  I tEL  above  a  critical  threshold, 
they became activated and migrated to the outer periarteri- 
olar lymphoid sheath  (PALS), after which they disappeared 
within  3  d  without making antibody,  irrespective  of their 
stage of maturation. The rapid loss of Ig-Tg B cells did not 
1Abbreviations used in this paper: CSFE, 5-carboxyfluorescein  diacetate-suc- 
cinimidyl ester; Dbl-Tg, double-transgenic mice; GC, germinal center; 
Ig-Tg, Ig-transgenic mice; HEL, hen egg lysozyme;  mHEL, membrane- 
bound form of HEL; OP,  outer PALS; PALS, periarteriolar lymphoid 
sheath; sHEL, soluble form ofHEL; TBS, Tris-buffered saline. 
occur on transfer into sHEL-Dbl-Tg recipients,  apparently 
because  of insufficient  antigen  binding  by their  Ig recep- 
tors.  When the B  cells  were given  cognate T  cell  help  at 
the  time  of transfer  into  sHEL-Tg  recipients,  however, 
they  migrated  through  the  outer  PALS  into  the  follicles 
and red pulp and secreted significant amounts of anti-HEL 
antibody.  Thus,  the  fate  of self-reactive B  cells  depended 
both on the degree of Ig receptor engagement by self-anti- 
gen and on the availability ofT cell help. 
Materials and Methods 
Mice.  Transgenic  mouse  lines  and  conventional  inbred 
C57BL/6 036) and 036 ￿  B10.BR)F 1 strains of mice were housed 
under standard  conditions in the Institute's animal facility. Hem- 
izygous Ig-Tg and HEL-Tg lines  were maintained  on a B6 or 
036 X  B10.BR)F 1 background by back-crosses  with  nontrans- 
genic mice. The Ig-Tg mice belonged to the MD4 line,  and the 
B cells from this line expressed high a~nity IgM and IgD recep- 
tors for HEL (11). In HEL-Tg mice, HEL was expressed either in 
soluble form (sHEL-Tg) under control of the mouse metallothio- 
nein-I promoter (lines ML4, ML5)  (12) or as an integral  mem- 
brane protein (mHEL-Tg) under control of the H-2 class I pro- 
moter (lines KLK9 and KLK3)  (8). Of the two lines ofsHEL-Tg 
mice  used,  line  ML4  expressed  low  serum  levels  of  HEL 
("~  ng/ml), but this concentration could be increased  to "-,100 
ng/ml by inducing the metallothionein  promoter with  25  mM 
zinc  sulphate  in  the  drinking  water  (12),  while  line  ML5  ex- 
pressed higher constitutive levels of HEL (15-20 ng/ml) (7). Un- 
less otherwise stated in the text, sHEL-Tg mice were of the ML5 
line. B6 sHEL-Dbl-Tg mice were generated by crossing sHEL-Tg 
mice with  Ig-Tg mice,  and  were  used  as  recipients  of CFSE- 
labeled cells when they were between 6 and 10 wk old. TCR-Tg 
mice  specific  for  the  COOH-terminal  peptide  of moth  cyto- 
chrome C  (MCC8v-103) in the context of IE  k (13) were bred on 
an F1 036 X B10.BR) background. 
Antigens.  HEL (Sigma Chem. Co., St. Louis, MO) was puri- 
fied as described in (14). A heptadecapeptide  (KANERADLIAYL- 
KQATK) identical  to the COOH terminus of moth cytochrome 
C  (MCCsv_I03) was  synthesized  at  the  Queensland  Institute  of 
Medical  Research.  TCR-Tg  mice  were  primed  with  10  b~g 
MCC87_103 i.v.  1  d  before  harvesting  of ceils from  peripheral 
lymph nodes and spleens for adoptive transfer. 
Antibodies.  The  following  mAbs  were  used  (specificities 
bracketed):  HyHEL5 (HEL [15]); RA3-6B2 03220  [16]), B3B4 
(CD23 [17]), RS3.1  (IgM  ~ [18]), AF6 15.1 (IgD  ~ [19]), RL172.4 
(CD4  [20]),  3.155  (CD8  [21]),  and  HO13.4  (Thy  1.1  [22]). 
HyHEL5 was biotinylated by standard methods. Polydonal rabbit 
anti-HEL antiserum  was  a  kind  gift  from Dr Helen  Pritchard- 
Briscoe (University of Sydney, Sydney, Australia), which was pro- 
duced  by  immunizing  a  rabbit  with  1  mg/n~l  HEL  in  CFA 
(Sigma). Before using any antibody preparation,  aggregates were 
removed  by  centrifugation  in  an  Airfuge  TM  (Beckman  Instru- 
ments, Palo Alto, CA) at 28 psi for 15 min. 
CFSE Labeling.  CFSE (Molecular  Probes,  Eugene, OR) was 
diluted to 5 mM in DMSO, aliquotted  and stored under desic- 
cating conditions at -20~  until used. Mice were killed by cervi- 
cal dislocation,  and the spleens removed and then gently pressed 
through a sieve using a syringe plunger.  Cells were suspended  in 
RPMI 1640 supplemented with 20 mM Hepes, 0.01  M  sodium 
bicarbonate,  50  mg/liter penicillin,  100  mg/liter  streptomycin, 
and 10% FCS (Commonwealth Serum Laboratories  [CSL], Vic- 
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P,  PMI/10%  FCS.  Cells  were  spun  down  and  resuspended  in 
Tris-ammonium chloride lysis  buffer solution (2.06  g/liter Tris 
and 7.47 g/liter ammonium chloride, pH 7.2) for 3 rain at room 
temperature. After underlaying the suspension with FCS, the cells 
were pelleted by centrifugation and washed once in RPMI 1640 
(without  supplemental protein),  then  resuspended  at  5  ￿  107 
cells/ml in R.PMI 1640 prewarrned to 37~  The CFSE stock so- 
lution was diluted 1/10 in RPMI  1640 and added to the warmed 
cell suspension. Different CFSE  doses  were  used to  distinguish 
between  cells  of Ig-Tg versus  non-Tg origin.  To  achieve  the 
higher fluorescence intensity, 10 I*l/ml of the diluted CFSE solu- 
tion was added to the cell suspension, whereas for the lower in- 
tensity, 2.5 bd/rnl was used. The suspension was incubated with 
CFSE for  10  rain at 37~  with inversion every 3-4 rain, after 
which several volumes of ice-cold R.PMI/10% FCS were added 
to stop the reaction. Cells were  then washed twice in the same 
medium and mixed with cells labeled with the alternate CFSE in- 
tensity. The ratio of mixing ofnon-Tg and Ig-Tg cells, as well as 
the number of cells injected intravenously into recipient mice, is 
stated in the figure legends. To assist with flow cytometric analy- 
sis in certain experiments, the Ig-Tg cells were labeled at one or 
other CFSE intensity. 
Preparation and Staining  of Cell Suspensions from  Recipient Mice. 
At each time point after transfer of CFSE-labeled cells,  mice for 
analysis were  anesthetized with diethyl ether,  bled from the tail 
vein (0.5 ml into 30 ~1 heparin or 0.5 ml of Alsever's solution), 
and killed by cervical dislocation. The spleen and both inguinal 
lymph nodes  (where needed) were removed and placed in PBS 
supplemented with  2%  FCS  and 0.1%  sodium azide  ("staining 
medium") at 4~  Approximately one quarter of each spleen was 
embedded in Tissue Tek OCT (Bayer, Elkhart, IN), snap-frozen 
in liquid nitrogen, and stored at  -70~  while cell suspensions 
were made from the lymph nodes and remainder of the spleen. A 
suspension of PBLs was prepared by centrifuging blood over Fi- 
coll-Hypaque, density 1.0875.  Cell suspensions from the spleen, 
lymph node, and blood were  washed twice in staining medium 
and then labeled with fluorescent antibodies. HEL-binding cells 
were detected by a three-stage sandwich stain: (a) HEL (200 ng/ 
ml;  Sigma);  (b)  biotinylated HyHEL5;  and  (c)  streptavidin-PE 
(Caltag  Laboratories,  South  San  Francisco,  CA),  streptavidin- 
Quantum red  (Sigma), or streptavidin APC  (Molecular Probes). 
B220-expressing cells  were identified by staining with unconju- 
gated RA3-6B2 then Texas red- or PE-conjugated goat anti-rat 
IgG (Caltag). After resuspending in staining medium (for imme- 
diate  analysis)  or  I% paraformaldehyde in PBS  (for analysis the 
next day),  cells  were  analyzed on a  FACStar  TM  or FACScan  TM 
flow  cytometer  (Becton-Dickinson  &  Co.,  Mountain  View, 
CA). Listmode data were collected with or without live gating on 
CFSE + cells on 10,000-20,000 cellular events and were analyzed 
using LYSIS 2.0 software (Becton Dickinson). 
Immunohistology.  Frozen tissue samples were sectioned at 5 Izm 
and allowed to dry overnight before storage at -20~  in foil. For 
staining, the slides  were thawed,  fixed in acetone (10 min), and 
washed twice in Tris-buffered saline (TBS; 7.88 g/liter Tris-HC1 
and 8.76 g/liter sodium chloride, pH 7.6). Staining was then car- 
tied  out  in  30-rain  stages  (shielded  from  the  light)  with  two 
5-min washes between each.  All washes were  done with TBS, 
except for the wash immediately before application of the first an- 
tibody, in which the TBS was supplemented with 30% horse se- 
rum (CSL). After staining, slides were stored in antifade (2.66 g/liter 
1,4-diazabicyclo-[2.2.2]octane  [DABCO]  in  90%  glycerol  and 
10% PBS) and photographed on a Leitz DMRBE fluorescent mi- 
croscope  (Leica,  Wetzlar,  Switzerland). HEL-binding cells  were 
detected by a three-stage sandwich stain: (a) HEL; (b) rabbit-anti- 
HEL antiserum; and (c) sheep anti-rabbit Ig F(ab')2 directly con- 
jugated to fluorescein (Silenus Laboratories, Hawthorn, Victoria, 
Australia).  B220  cells  were  stained  using RA3-6B2  and  Texas 
red-conjugated goat anti-rat IgG (Caltag). 
Depletion of Mature B Cells  fiom the Bone Marrow.  Bone  mar- 
row was harvested from both the tibiae and femora of donor mice 
by two-directional medullary flushing with HBSS supplemented 
with  10%  FCS  (HBSS/10%  FCS).  After washing twice in this 
medium, cells were resuspended at ~30 million cells/ml in a 1/100 
dilution of biotinylated anti-CD23. Cells were incubated at 4~ 
for  20  min, then washed  twice  and resuspended at  30  million 
cells/ml. Streptavidin-coated magnetic beads (M280-SA; Dynal, 
Oslo, Norway) were added at a bead/cell ratio of 1:1, which gen- 
erated a bead/target cell ratio of"-~20--30:1. After 30 min of con- 
tinuous rotation at 4~  bound cells were removed by two rounds 
of magnetic depletion (2 min, then 5 min), and were resuspended 
in either 1 ml heparinized syngeneic nontransgenic mouse blood 
(to  reduce  cell clumping) for immediate injection or in RPMI 
1640 for CFSE labeling. 
Bone Marrow Chimeras.  ML5 sHEL-Tg mice aged at least 3 mo 
were  lethally irradiated (950 Rad)  and reconstituted by intrave- 
nous injection of a  minimum of 2.5  ￿  106 bone marrow  cells 
from MD4  Ig-Tg donors, prepared  as described previously (7). 
The resultant chimeras were used 7 wk after reconstitution. 
Culture of lg-Tg B Cells in Mouse Sera.  Spleen cells from MD4 
Ig-Tg mice were harvested in P,  PMI 1640. 1 million cells (25 btl) 
were added to 150 ~1 normal mouse serum, serum from sHEL-Tg 
mice,  serum from MD4  ￿  ML5  sHEL-Dbl-Tg mice,  R.PMI/ 
10% FCS, or P,  PMI/10% FCS with 20 ng/ml HEL. After incu- 
bation at 37~  in 5% CO2 for 5 h, the cells were stained for ex- 
pression of IgM  ~ (biotinylated RS3.1  and streptavidin-Quantum 
red [Sigma]), IgD  a (fluoresceinated AMS 15.1), and B220 (RA3- 
6B2 and PE-conjugated goat anti-rat IgG [Caltag]). Three-color 
analysis was performed on a FACScan  | 
Purification of B Cells  fiom Spleen and Peptide Pulsing.  Spleen  cells 
from mice on a B6 or F1 background were depleted of adherent cells 
by panning on plastic petri dishes (Becton Dickinson) at 37~  for 
1 h.  The nonadherent cells were gently resuspended, then incu- 
bated on ice with rat IgM antibodies to CD4, CD8, and Thy 1.1 
(see above), followed by a 30-rain incubation with young rabbit 
complement (C-six Diagnostics, Mequon, WI) at 37  ~  The cells 
were washed with cold medium and assessed for purity by flow 
cytometry, which showed that CD4 + and CD8 + cells represented 
less than  1% of purified splenocytes. The  cells  were  then resus- 
pended at  5  ￿  107/ml and were  incubated for 2  h  at 37~  in 
P,  PMI  1640 containing 1 ~M MCC87_103. CFSE was added for 
the final 10 rain of the incubation, as described previously, and the 
cells were then washed three times in cold RPMI before adoptive 
transfer. 
Serum HEL and Anti-HEL Antibody Assays.  Anti-HEL  IgM  ~ 
antibodies were detected by ELISA. 96-well flat-bottomed plates 
were coated with 10 I*g/ml HEL in NPP buffer (1.54 g/liter so- 
dium carbonate, 2.43 g/liter sodium bicarbonate, and 20 mg/liter 
magnesium chloride.6H20, pH 9.6), washed in PBS with 0.05% 
Tween  20,  and  blocked  with  1%  BSA  (Pentex;  Miles  Inc., 
Kankakee,  1L)  in PBS.  Serum samples  were  added  and bound 
lgM  ~ was detected with biotinylated R.$3.1  in the presence of 1% 
FCS and 1% skim milk. After a further incubation with alkaline 
phosphatase-conjugated  avidin  (Sigma),  the  plates  were  devel- 
oped with 1 mg/ml p-nitrophenyl phosphate disodium (Sigma) in 
NPP buffer.  Optical density readings (OD  405  riM)  were  stan- 
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bridoma.  The  serum  concentrations  of HEL were  measured as 
described previously (7). 
Results 
Short Life Span of Splenic  Ig-Tg B  Cells  on Encounter with 
Soluble or Membrane-bound  Self-Antigen.  The  fate  of mature 
Ig-Tg B  cells upon encounter with endogenous self-antigen 
was determined by injecting CFSE-labeled spleen cells from 
Ig-Tg mice into sHEL-Tg, mHEL-Tg,  or non-Tg recipi- 
ents. Before injection, labeled cells were mixed with spleen 
cells from non-Tg mice labeled with CFSE at a lower fluo- 
rescence  intensity that  served as an  internal control.  18  h 
after transfer, CFSE + B  cells made up ~1.4%  of host lym- 
phocytes in the spleens of non-Tg recipients, a  value that 
decayed slowly over the subsequent 2  d  (data not shown)￿9 
The  number  of Ig-Tg B  cells relative to  non-Tg  B  cells, 
however, remained constant throughout the 3-d period of 
observation in the spleen, blood, and lymph nodes (Figs. 1 
and  2).  By  contrast,  in  sHEL-Tg recipients, there was  an 
early loss of Ig-Tg B  cells from the blood and prominence 
of the same cells in the spleen at day 1  (Figs. 1 and 2), fol- 
lowed by  their  disappearance during  the  next  48  h.  The 
disappearance of Ig-Tg B  cells from the blood was exam- 
ined at earlier time points  (6-18  h),  and  was  found  to be 
complete by  12  h  (Fig. 3).  In mHEL-Tg  recipients, pro- 
gressive loss of transferred Ig-Tg cells from both the blood 
and  spleen  occurred  from  the  earliest time point  (Figs.  1 
and 2). Cell surface Ig on transferred B  cells showed down- 
regulation in both  sHEL and mHEL  recipients, consistent 
with antigen encounter  (Fig.  1).  In neither type of recipi- 
ent was the disappearance of Ig-Tg B  cells from the spleen 
accompanied by late migration to the lymph nodes (Fig. 2, 
lower graph),  nor was  there any suggestion of cell division, 
which  would  have  reduced  the  CFSE  intensity  per  cell 
(Fig.  1).  Thus,  cell  loss was  most  likely to  have  resulted 
from death in situ.  Interestingly, the  HEL-binding B  cells 
increased in size in sHEL-Tg recipients and markedly so in 
mHEL-Tg recipients by comparison with non-HEL-bind- 
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Figure  1.  Dot plots of trans- 
ferred  CFSE  +  B  cells  in  the 
spleens of recipient non-Tg (up- 
per row), ML5 sHEL-Tg  (middle 
row), and KLK9 mHEL-Tg (lower 
row) mice over a 3-d time course. 
Donor  spleen  cells from  MD4 
Ig-Tg mice were labeled CFSE  hi 
and  mixed  in  a  ratio  of 2.7:1 
with  spleen cells from  non-Tg 
mice labeled CFSE  I~ 30 million 
cells (based on  the  prelabeling 
counts)  were  injected  intrave- 
nously; of these, 50-60%  were 
B220 +.  Data were  collected by 
live  gating  on  CFSE  intensity, 
with  subsequent  analysis gating 
on  small lymphocytes (by light 
scatter) and 13220 expression. In 
non-Tg and sHEL-Tg recipients, 
a minor population of CFSE  I~ B 
cells bind  HEL  at  high  levels; 
these  presumably represent  B 
cells  from  Ig-Tg  donors  that 
have  labeled  ine~ciently  with 
CFSE. In mHEL-Tg  recipients, 
the non-Tg B cells all show low 
level HEL-binding, possibly be- 
cause of the acquisition of small 
amounts  of  recipient-derived 
mHEL after transfer. 
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Figure  2.  Numbers  of Ig-Tg B cells relative to non-Tg B cells after 
transfer into non-Tg (open circles), sHEL-Tg (closed circles), or mHEL-Tg 
(open triangles) recipients harvested from the blood (top), spleen (middle), or 
lymph node (bottom) in the experiment detailed in the legend to Fig. 1. 
Lines are drawn through median values. 
ing control cells from the same mice (Fig. 4), a finding that 
was suggestive of B  cell activation immediately before their 
disappearance. 
Ig-Tg  Splenic  B  Cells  Migrate  to  the  Outer  PALS  (OP)  on 
Encounter with Soluble Antigen.  The microanatomical posi- 
tioning  of CFSE +  Ig-Tg B  cells  during the  first  3  d  after 
transfer  was  determined  by  staining  frozen  sections  of 
spleens  from non-Tg and sHEL-Tg recipients.  In non-Tg 
recipients, HEL-binding B ceils were present in the follicles 
throughout the  study period  (Fig.  5,  a  and  b),  whereas  in 
sHEL-Tg recipients, they were largely confined to the out- 
ermost margins of the PALS at its interface with the B  cell 
Figure 3.  Numbers  of HEL-binding Ig-Tg B ceils relative to cotrans- 
ferred non-HEL-binding  non-Tg B cells in the blood during the first 
18 h after intravenous injection into non-Tg (open circles) or sHEL-Tg 
(closed circles) recipients. Spleen cells from Ig-Tg mice were labeled CFSE  1~ 
and mixed in a ratio of 1:1 with non-Tg spleen cells labeled CFSE  hi. Ap- 
proximately 40 million cells (based on posdabeling counts) were injected. 
The number of CFSE  I~ HEL-binding B cells is expressed relative to the 
number of CFSE  ~ non-HEL-binding B cells. Lines are drawn through 
median values. 
zone (Fig.  5, c and d).  By day 3, HEL-binding B  cells had 
decreased markedly in number,  consistent with the  previ- 
ous  quantitative  analysis  by flow cytometry (Fig.  2).  The 
]ocahzation of Ig-Tg B  ceils  after transfer into  mHEL-Tg 
recipients  could not be as  readily determined  because  ex- 
pression  of mHEL by host B  ceils  interfered with the  de- 
tection of anti-HEL-binding activity on transferred B  cells. 
Movement  into  the  OP Depends  on  Ig Receptor Engagement 
Reaching a Critical Threshold.  The  increase  in  the  size  of 
Ig-Tg B cells (Fig. 4) and downregulation of their Ig recep- 
tors  (Fig.  1)  after  transfer  into  HEL-expressing  recipients 
suggested  that  Ig receptor  engagement  by  antigen  was  a 
prerequisite  for migration  into  the  OP.  To  confirm this, 
Ig-Tg B  cells  were  transferred  into  mice from a  different 
sHEL-Tg line  (ML4) that expresses HEL at concentrations 
below the threshold needed to tolerize the B  ceil compart- 
ment  (12).  In other words, the B  cells in these mice were 
"ignorant" of self-antigen. As shown in Fig. 5 e, the trans- 
ferred  HEL-binding B  cells  were detected in the  follicles, 
where  they  persisted  during  the  next  2  d.  In  a  second 
group of ML4 mice, use was made of the inducibility of the 
metailothionein promoter to increase the levels of endoge- 
nous HEL by zinc feeding (12).  This manuever resulted in 
relocation ofHEL-binding B cells to the OP (Fig. 5f) in a 
manner identical to that observed in ML5 sHEL-Tg recipi- 
ents expressing higher resting levels of antigen (Fig. 5 c). 
Thus,  the  positioning of self-reactive B  cells in the OP 
was shown to depend on engagement of surface Ig by anti- 
gen, provided its  concentration exceeded a critical thresh- 
old, whereas B  ceils exposed to antigen below that thresh- 
old were  found in the  follicles.  These  observations  raised 
the  question  of why  a  significant  number  of B  cells  are 
found in  the  follicles  of tolerant  sHEL-Dbl-Tg mice  (11) 
expressing sufficient levels of self-antigen to engage the  Ig 
receptor. To investigate this paradox,  CFSE  l~ Ig-Tg spleen 
cells  were  cotransferred  with  CFSE  hi  non-Tg spleen  cells 
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Figure 4.  Relative  cell size (by forward light scatter) of CFSE  ~° non- 
HEL-binding  B cells (left histograms as labeled) and CFSE  hi HEL-binding 
B cells (right histograms) after transfer into non-Tg (top), sHEL-Tg (middle), 
and mHEL-Tg recipients (bottom) in the experiment detailed in the leg- 
end to Fig. 1. 
into three groups of recipients: (a) control non-Tg mice; (b) 
sHEL-Tg mice; and (c)  sHEL-Dbl-Tg mice.  6-10 wk-old 
recipients were  chosen  to  minimize the  number of non- 
HEL-binding B  cells of normal life span that  might com- 
pete with short-lived HEL-binding (self-reactive) B  cells in 
the  follicle  (9).  In  sHEL-Tg  recipients,  transferred  HEL- 
binding B  cells rapidly disappeared  from  the spleen as be- 
fore, whereas the cells persisted in the other two groups of 
recipients  (Fig.  6  A).  Similar results  were  obtained when 
tolerant sHEL-Dbl-Tg spleen cells were substituted for Ig-Tg 
donor spleen cells (Fig. 6  B). Interestingly, downregutation 
of surface  Ig on HEL-binding B  cells from  sHEL-Dbl-Tg 
recipients  was  much  Iess  (about  twofoId)  compared  with 
sHEL-Tg recipients (10-20-fold, Fig. 6  C), suggesting that 
receptor engagement by antigen was not equivalent in the 
two  types of recipients.  Since sHEL-Dbl-Tg mice contain 
residual amounts of anti-HEL antibody and large numbers of 
anti-HEL B  cells to which HEL can bind (4), the effective 
antigen concentration in these mice might have been lower 
than in sHEL-Tg recipients. The finding that the mean con- 
centration of HEL detected by ELISA was 9.5 ng/ml in se- 
rum from sHEL-Dbl-Tg mice and 15 ng/ml in serum from 
sHEL-Tg mice is consistent with this conclusion. To dem- 
onstrate formally a  reduction in the level of available anti- 
gen,  Ig-Tg  spleen  cells  were  cultured  in  serum  obtained 
from  sHEL-Tg  or sHEL-Dbl-Tg mice.  After  5  h,  down- 
regulation of surface IgM  a and IgD  a was much greater on B 
cells exposed to serum from sHEL-Tg donors than on B  cells 
exposed to sHEL-Dbl-Tg serum (Fig. 6 D). Taken together, 
these findings suggested that migration of transferred Ig-Tg 
B  cells into the outer PALS required levels of available an- 
tigen higher than those present in sHEL-Dbl-Tg mice. 
Relocation  of Mature Ig-Tg B  Cells  in Response  to Endoge- 
nous Antigen  Is  Identical to Antigen Administered  Exogenously. 
The positional changes of mature HEL-binding B  cells upon 
encounter  with  endogenous  (self)  HEL  appeared  to  be 
identical to the behavior orb  cells reported previously after 
encounter with exogenous (foreign) antigen (23).  To con- 
firm  this  in  the  current  model,  unlabeled  Ig-Tg  B  cells 
were  injected  into  either  sHEL-Tg  recipients  or  non-Tg 
recipients which were  then challenged with  50  Ixg i.p.  of 
exogenous HEL,  a dose sufficient to give a serum concen- 
tration in excess  of 15  ng/ml for ~4  h  (data  not shown). 
The repositioning of Ig-Tg B  cells in the OP was identical 
whether  the  antigen encountered was  endogenous  (trans- 
genic) or given by injection (Fig.  5, i-k).  This experiment 
Figure 5.  Fluorescent micrographs of frozen sections from spleens of recipients after injection of spleen ceils from lg-Tg mice. HEL-binding cells are 
stained green and B220 + cells are stained red. (a-d) CFSE-labeled spleen cells from Ig-Tg mice were injected into non-Tg (a and b) or sHEL-Tg recipi- 
ents (c and d). Two time points are shown, day 1 (a and c) and day 3 (b and d). (e and  f) 40 million unlabeled spleen ceils from an Ig-Tg mouse were in- 
jected into recipients from the low HEL--expressing  line ofsHEL-Tg mice (ML4), which were then given either ordinary drinking water (e) or 25 mM 
zinc sulphate (f) from day 1 to 3, at which time spleens were harvested. (g and h) Bone marrow cells from Ig-Tg mice were depleted ofCD23  -~ mature 
B cells and resuspended in syngeneic non-Tg mouse blood. 180 million unlabeled leukocytes were injected into non-Tg (g) or sHEL-Tg (h) recipients, 
and spleen sections were prepared I d later• A small "island" orB220 + cells is seen to indent the PALS in H. (i-k) 60 million unlabeled spleen cells from 
an Ig-Tg mouse were injected into either non-Tg recipients given intraperitoneal saline (i), sHEL-Tg recipients given intraperitoneal saline (j), or non- 
Tg recipients given 50 Ixg intraperitoneal HEL (k), and spleen sections were prepared 1 d later. (l) The spleen is compartmentalized into red and white 
pulp, the latter containing  distinct T and B cell zones• The periarteriolar lymphoid sheath (PALS) is comprised predominantly  ofT ceils and forms a con- 
centric cuff around the central arteriole. The PALS is surrounded by the follicle (f) containing  B220 + B cells. The red pulp is separated from the white 
pulp by the marginal zone composed largely of B cells, which in turn is separated from the inner mantle zone by the marginal sinus• T cell-dependent B 
cell activation occurs in the outer PALS fOP), which leads to B cell differentiation into two anatomically distinct but clonally reiated populations, namely 
proliferative foci (PF) and germinal centers (GC). PF appear first, arising as cellular clusters in the outer PALS which evolve into larger aggregations in the 
bridging zones and red pulp. GC arise when activated B cells penetrate the mantle zone. A  B 
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Gated on B220-positive  lymphocytes also provided further  confirmation  that CFSE  labeling did 
not influence B  cell migratory patterns, since the histological 
results were  similar to those  obtained  when  CFSE-labeled 
cells were used (Fig. 5, a-d). 
Repositioning of B  Cells in the OP Does Not Depend on the 
Stage of Maturation.  The  rapid  disappearance  of  mature 
Ig-Tg B  cells on encounter with antigen after transfer into 
sHEL-Tg recipients is reminiscent  of the  short life span of 
HEL-binding  cells  when  previously  measured  in  tolerant 
sHEL-Dbl-Tg mice by Brd labehng (7). In the latter mice, 
however,  B  cells first  encounter  self-antigen  at  an  imma- 
ture  stage  of their  development  within  the  bone  marrow 
(11), whereas in the  current experiments,  B  cells were ex- 
posed to self-antigen  after reaching maturity.  Since imma- 
ture B  cells are thought  to be peculiarly sensitive to toler- 
ance  induction  (24,  25),  it  was  necessary  to  test  whether 
the  stage of maturation  might influence  B  cell positioning 
and  lifespan.  This  was  accomplished  by  depleting  mature 
CD23 + B cells from suspensions of bone marrow using mag- 
netic beads to leave immature B hneage cells and cells of the 
other  hemopoietic  lineages.  A  mixture  of CD23-depleted 
marrow  cells  from  Ig-Tg and  non-Tg  mice,  labeled  with 
CFSE  at  different  fluorescence  intensities,  was  transferred 
into non-Tg, sHEL-Tg, or mHEL-Tg recipients. 
In  all recipients,  mitotic  differentiation  of CFSE +  mar- 
row  cells  continued  after transfer,  resulting  in  progressive 
reduction  in  cell size  (caused by differentiation,  Fig.  7  A) 
and  CFSE  intensity  (caused  by  cell  division,  Fig.  7  B). 
Nevertheless,  the fate of immature B  cells that had not di- 
vided (i.e., retained their original CFSE intensity)  could be 
followed  by  restricting  analysis  to  CFSE  hi  HEL-binding 
cells.  An  initial  increase  in  the  relative  number  of B220 + 
cells from Ig-Tg donors was observed in all recipients be- 
tween 6  and  18 h  (Fig.  7  C) because of more rapid differ- 
entiation  of Ig-Tg B  cells by virtue  of their prerearranged 
Ig  genes  (11).  From  18  h  onwards,  however,  immature 
HEL-binding  B  cells of the  original CFSE  intensity disap- 
peared rapidly from the spleens of sHEL-Tg and mHEL-Tg 
recipients,  while persisting in non-Tg mice  (Fig.  7,  B  and 
C).  A  decrease  in  the  number  of divided  (CFSE l~  HEL- 
binding B  cells was also  seen in sHEL-Tg compared with 
normal  recipients  (Fig.  7  B).  When  the  positioning  of 
HEL-binding immature B  cells was examined histologically 
18  h  after  transfer,  preferential  migration  into  the  OP  of 
splenic follicles was again observed in sHEL-Tg recipients 
(Fig.  5, g  and h)  in a manner identical to that of mature B 
cells (Fig. 5 c). 
It could be argued that in this experiment, encounter with 
self-antigen did not take place immediately after the initial 
expression of Ig receptors, as occurs in sHEL-Dbl-Tg mice. 
To overcome such a potential problem, radiation chimaeras 
were  created by reconstituting  lethally irradiated  sHEL-Tg 
mice with  Ig-Tg marrow.  7  wk later,  bone  marrow  cells 
were  harvested and  depleted  of CD23 +  mature B  cells,  as 
described  previously.  After  transfer,  immature  HEL-bind- 
ing  B  cells  that  had  been  exposed  to  antigen  throughout 
their  development  in  the  marrow  were  again  found  pre- 
dominantly in the OP ofsHEL-Tg mice and the follicles of 
non-Tg recipients  (data not shown).  Two conclusions  can 
be drawn from these data.  First,  homing to the PALS was 
governed  by  antigen-dependent  signaling  rather  than  by 
the  maturational  stage  of the  B  cell.  Secondly,  tolerant  B 
cells  that  colonize  the  follicles  of sHEL-Dbl-Tg mice  can 
be induced  to migrate into the PALS when exposed to the 
higher levels of available HEL present in sHEL-Tg mice. 
Rescue  of  lg-Tg  B  Cells  by  Provision  of  T  Cell  Help. 
The transfer experiments described to date have shown that 
HEL-binding Ig-Tg B  cells respond in an identical manner 
on exposure to self- or foreign antigen by migrating in an 
activated state  (Fig.  4)  to the  outer PALS  (Fig.  5., c and  k). 
In the  case  of B  cells with  specificity for foreign  antigen, 
this  is the  site where  T  cell help  initiates  a productive  re- 
sponse  (26,  27).  On  the  other  hand,  self-reactive  B  cells 
(i.e., Ig-Tg B  cells transferred into sHEL-Tg recipients) re- 
ceive  no  helper  signals  since  the  T  cell  compartment  of 
sHEL-Tg mice is known to be tolerant (12). This raised the 
possibihty that a lack of T  cell help could have contributed 
to  the  rapid  loss  of self-reactive  B  cells  from  the  outer 
PALS.  If so,  then  provision of help  might be  expected  to 
rescue  the  transferred  self-reactive B  cells  and  allow them 
to  survive  and  differentiate  into  antibody-secreting  cells. 
Purified  CFSE-labelled  HEL-reactive  B  cells,  prepulsed 
with  cytochrome  peptide,  were  cotransferred  with  acti- 
vated T  cells from TcP,.-Tg mice specific for cytochrome 
peptide in the context of IE  k. Both T  and B  cells were de- 
rived from F 1 mice expressing IE  k which  is necessary both 
for positive thymic  selection  of the  transgenic  T  cells  and 
for presentation  of cytochrome peptide by B  cells.  The  T 
cells were activated by intravenous injection of 10 btg cyto- 
chrome  peptide  1  d  before transfer,  a  protocol  which  has 
been  demonstrated  to produce  high  levels of activation in 
about 80% of CD4 + TcR.-Tg T  cells  (Wikstrom,  M.,  and 
B.  Fazekas  de  St.  Groth,  unpublished  observations).  As  a 
control,  activated  F1  T  cells were  cotransferred  with pep- 
tide-pulsed  CFSE-labelled  HEL-reactive  B  cells  from  B6 
(IE-negative) mice unable to present cytochrome peptide. 
Figure 6.  Spleen  cells from Ig-Tg (A) or ML5xMD4 sHEL-DbI-Tg mice (B) were labeled CFSE  I~ and mixed in a 1:1 ratio with spleen cells from non- 
Tg mice labeled CFSE  hi. 30 million cells were injected intravenously into non-Tg, sHEL-Tg, or sHEL-Dbl-Tg mice. The latter were aged between 6 
and 10 wk. (A and B) The number of HEL-binding CFSE  l~ cells are expressed relative to cotransferred non-HEL-binding  CFSE  hi cells. Lines are drawn 
through median values. (C) Histograms of transferred CFSE  + B cells obtained from the spleens of non-Tg, sHEL-Tg, and sHEL-DbI-Tg recipients (as 
shown) 1 d after transfer. The left panels represent Ig-Tg donors, and the right panels represent sHEL-Dbl-Tg donors. Gating is on small lymphocytes (by 
light scatter), B220 expression, and low CFSE intensity, the latter representing cells of Ig-Tg (left) or sHEL-Dbl-Tg (right) origin. The lower histograms 
represent the degree of HEL binding by endogenous (CFSE-) B cells in sHEL-Dbl-Tg recipients. (D) Expression of transgenic IgM  ~ and IgD  ~  by Ig-Tg 
B cells cultured for 5 h in medium (upper left), medium with 20 ng/ml HEL (upper right), normal mouse serum (lower  left), serum from sHEL-Tg mice 
(lower middle), or serum from sHEL-Dbl-Tg mice (lower  tight). Gating is on small lymphocytes (by light scatter characteristics) and B220 expression. 
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 24 h  after transfer, B6 and F 1 HEL-binding B  cells were 
both  located  at  the  interface  between  the  PALS  and  the 
follicles (Fig. 8 A,  upper panels),  but neither population had 
divided (Fig. 8 B). By day three,  F 1 B-cells which were ca- 
pable  of presenting MCC  peptide  to TcR-Tg  T-cells had 
proliferated throughout the PALS (Fig. 8 A,  middle left panel 
and Fig.  8  B), whereas the majority of B6 HEL-binding B 
cells had disappeared without  undergoing  cell division and 
could  not  be  detected  in  the  lymph  nodes  (data  not 
shown).  2  d  later (day five)  a significant proportion  of the 
progeny of the  proliferating  F 1 HEL-binding  B  cells were 
detectable either within the red pulp as proliferative loci of 
antibody-secreting  cells,  or in the follicles where they had 
developed into  immature  germinal centres  (Fig.  8  A,  lower 
left panels)  (28). Although the latter were difficult to discern 
due  to  downregulation  of surface  Ig,  they  clearly had  the 
appearance of germinal centres based on their location and 
binding  of peanut  agglutinin  (data  not  shown).  Interest- 
ingly,  examination  of individual  follicles taken at the same 
time point revealed B  cells in varying stages of differentia- 
tion and movement suggesting that T-B cell interactions in 
individual  follicles  may  proceed  at  different  rates.  When 
HEL-specific IgM  a antibody was assayed, recipients ofF1 B 
cells,  but  not  B6  B  cells,  produced  significant  amounts  of 
antibody  (11.5  I~g/ml versus 0.01  I~g/ml on day 5). Thus, 
provided  that  T  cell  recognition  of B  cell  MHC  peptide 
complexes  takes  place,  self-reactive  B  cells  can  migrate 
through the T  zone into the follicles and red pulp of previ- 
ously tolerant hosts and mount an antibody response. 
Discussion 
The outcome  of the interaction  between  antigen  and B 
cell is thought  to depend  on several factors.  Some factors, 
such as the stage of maturation and the capacity to interact 
with other cells in the  environment,  are intrinsic  to the B 
cell itself, while  others  are related to the  properties  of the 
stimulating antigen and certain extrinsic influences,  such as 
availability of T  cell  help  (24,  29,  30).  Collectively,  these 
factors  determine  whether  activation  or  tolerance  occurs 
and, in the case of tolerance, whether it is mediated by de- 
letion or anergy. According to recent BrdU labehng studies 
in anti-HEL B  cell transgenic mice, a major difference be- 
tween tolerant and normal or activated (memory) B  cells is 
their life span. Thus, B  cells exposed to multivalent mHEL 
in bone marrow were shown to die rapidly (within  1-2 d) 
without migrating to peripheral lymphoid tissue (6), and B 
cells  exposed  to  ohgovalent  self-antigen  in  sHEL-Dbl-Tg 
mice, although they survived long enough to populate pe- 
ripheral  lymphoid  tissue,  still had  a  markedly reduced  life 
span (3-5  d). A  comparable decrease in the longevity of B 
ceils was also demonstrated by Finkelman et al. (31) after in 
vivo administration of highly cross-linked anti-IgD to non- 
Tg mice. By contrast,  normal B  cells or "ignorant"  B  cells 
that had been  exposed to  subtolerogenic  levels of antigen 
had  a  hfe  span  in  the  periphery  of 4-5  wk  (7).  In  other 
words,  the avidity of antigen exerts some influence  on the 
fate of B  cells in terms of their longevity and site of death, 
but other factors must be important as well.  The nature  of 
these factors and the precise positioning of B  cells after en- 
counter with antigen  were  therefore  examined  in vivo by 
tracking HEL-binding Ig-Tg-B cells labeled with CFSE af- 
ter transfer into normal or Tg recipients expressing HEL as 
a neo--self antigen. 
Virgin B  cells normally emigrate from the bone marrow 
to the OP or the marginal zone (27, 32). After exposure to 
foreign antigen, they are found in the OP and, after receipt 
of T  cell help, undergo activation to form proliferative loci 
in which  isotype switching  occurs  (27)  and  GC in which 
somatic  hypermutation  and  production  of memory  cells 
takes  place  (23,  28,  33-35).  When  mature  CFSE-labeled 
potentially  self-reactive  B  cells  from  Ig-Tg  mice  were 
transferred into mHEL or (ML5) sHEL-Tg recipients, they 
increased in size (Fig.  4)  and were rapidly recruited  to the 
spleen (Figs. 2 and 3) in a manner identical to foreign anti- 
gen-stimulated  virgin B  cells  (Fig.  5  k).  Not  surprisingly, 
self-reactive immature B  cells exposed to sHEL behaved in 
the same way as mature B  cells (Fig. 5, g and h). On immu- 
nohistology,  HEL-binding  B  cells  were  initially  found  in 
the OP in the same location as B  cells exposed to HEL as a 
foreign antigen  (Fig.  5  k).  They disappeared within  2-3  d 
(Fig.  1) without forming proliferative foci or GC, presum- 
ably as a result of death in situ  (Fig.  5, c and d).  This out- 
come  was  dependent  on  an  encounter  with  a  sufficient 
concentration  of antigen  to signal the B  cell through  its Ig 
receptors  since  mature  B  cells  transferred  into  another 
sHEL-Tg  recipient  (ML4),  which  expressed  much  lower 
levels  of available  antigen  (0.5  ng/ml  versus  15  ng/ml  in 
ML5),  migrated  to  the  follicles,  and  survived  during  the 
3-d period of study  (Fig.  5  e).  Taken together,  these find- 
ings indicated  that repositioning  of B  cells in the  OP  was 
neither  influenced  by the  stage  of maturation  nor by the 
nature of the antigen (self versus foreign), but it did require 
a critical threshold  of antigen.  Moreover,  the fact that ma- 
ture B  cells were lost as rapidly as immature B  cells is con- 
Figure 7.  Bone marrow suspensions from Ig-Tg and non-Tg mice were depleted of CD23 + mature B cells and then labeled with CFSE, Ig-Tg cells 
being labeled CFSE  hi and non-Tg cells CFSE  l~ A~er mixing in a 1:1 ratio (based on prelabeling counts), 33 million leukocytes were injected intrave- 
nously into non-Tg, sHEL-Tg, or KLK3 mHEL-Tg recipients. (A) Light scatter characteristics of transferred CFSE  § cells recovered from the spleens of 
non-Tg recipients 6 h (left), 1 d (middle), or 3 d (right) after transfer. Ellipses represent the lymphocyte gate used in B. (B) Characteristic dot plots of  B220 § 
cells from non-Tg (upper  panels) or sHEL-Tg (lower  panels) recipients 6 h (left), 1 d (middle), or 3 d (right) after transfer. Gating is as described in Fig 1. The 
CFSE  hl (Ig-Tg origin) B220  + cells that fail to bind HEL (lower  right quadrants) presumably represent slg- B lineage cells, or in the case of sHEL-Tg recip- 
ients, B cells that have downregulated surface Ig. (C) The number of HEL-binding CFSE  hi B cells (excluding  those that had divided to become CFSE  1~ rel- 
ative to CFSE  l~ non-HEL-binding  B cells after transfer into non-Tg (open circles) or sHEL-Tg (closed circles) mice in the spleen (left) and blood (right). Lines 
are drawn through median values. 
2323  Fulcher et al. a  Figure 8.  Effect  of T  cell help 
B-cells from H-2 b/k donor  B-cells from H-2 b donor  on the movement oflg-Tg B cells 
transferred into sHEL Tg recipi- 
Day 1  ents. (A) Fluorescent micrographs 
of frozen sections from spleens of 
H-2  bk sHEL-Tg mice taken 1, 3, 
and 5 d after transfer of preacti- 
vated anticytochrome TcR-Tg T 
cells and  CFSE-labeled Ig-Tg  B 
cells that had been pulsed in vitro 
with MCC peptide 87-103. The 
Ig-Tg B cells were obtained from 
either H-2  bk donors (left) or H-2  b 
donors  (right).  HEL-binding  B 
cells are stained green and B220  + 
cells red.  Day  1  sections, H-2  b 
Day 3  and  H-2  bk HEL-binding  B  cells 
are both  positioned  in  the  OP; 
day 3 sectons, H-2  bk HEL-binding 
B cells have prohferated, whereas 
the great majority of H-2  b B-cells 
have disappeared; day 5 sections 
e- 
:H  from  the  spleens of  recipients 
given H-2  t'k B cells reveal the fol- 
&  lowing:  (a)  PF  containing  anti- 
￿9  1"uS  body-secreting  cells (stained green) in 
the T cell  zone/red pulp bridge or 
the red pulp (top);  and (b) imma- 
....  ture GC containing HEL  + B cells 
CFSE  Gated on B220-positive lymphoeytes  with downregulated Ig receptors 
(stained  orange~yellow)  in the folli- 
cle  (bottom).  (B)  Dot  plots  of 
B220 + cells from recipient spleens obtained one (upper plots)  and three (lower plots)  days after transfer. Ig-Tg cells were labeled CFSE  hi (region 3, day 1) 
and non-Tg cells were labeled CFSE  1~ (region 4). Cell division is represented by a decrease in CFSE intensity, as shown in the lower left-hand panel (re- 
gion 1). The CFSE  hi B220  § cells that fail to bind HEL on day 1 (region 5) are probably B cells that have downregulated surface Ig, since by day 3, they 
behave in an identical fashion to HEL-binding B cells, being deleted in the absence ofT cell help (right-hand panel) and dividing in response to T cell help 
(left-hand panel, left of region 4). 
sistent with previous reports of induction of tolerance in pe- 
ripheral lymphoid tissue as well as in bone marrow (36, 37). 
The requirement for a critical threshold of antigen to di- 
rect self-reactive B  cells to the OP of tolerant sHEL-Tg re- 
cipients  raises  the  question  of why  they  are  apparently 
found  in  the  follicle rather  than  at  this  site in  the  corre- 
sponding sHEL-Dbl-Tg mice  (11).  According to  the  data 
presented here (Fig. 6), the concentration of antigen avail- 
able for engaging Ig receptors on transferred B  cells was less 
than expected in sHEL-Dbl-Tg recipients, possibly because 
of binding of circulating HEL  to  anti-HEL  Ig-Tg B  cells 
and/or  to  the  small  amounts  of residual  anti-HEL  lgM 
present  in  the  double  transgenic  mice  (4).  Consequently, 
the capacity of HEL to form the oligovalent complexes with 
serum  proteins  such  as  cx2-macroglobulin,  which  are  be- 
lieved to be a prerequisite for cross-linking of lg receptors 
by HEL (reference 38 and Fulcher, D.A., and P.W. Peake, 
unpublished observations), is likely to have been impaired. 
In the case of intact sHEL-Dbl-Tg mice, sufficient antigen 
is apparently present in the bone marrow to downregulate 
surface  Ig on  newly generated B  cells  (11)  and  to  impair 
surface  Ig-dependent  signaling function  (39,  40).  On  the 
other hand, this level of antigen appears insufficient to acti- 
vate these B  cells fully (39)  or to direct them to the PALS, 
and instead they migrate into the follicles. Nevertheless, B 
cells from sHEL-Dbl-Tg mice remain capable of respond- 
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ing in vivo to antigenic signals, as shown by their capacity 
to migrate into the OP on transfer into sHEL-Tg recipients 
(Fig. 6). Mthough a plausible explanation for the failure of 
B  cells from  sHEL-Dbl-Tg mice  to  migrate  to  the  outer 
PALS,  this  interpretation  relies on  the  assumption  that  B 
cells can undergo  three distinct fates on  exposure to  HEL 
over a serum concentration range of 0.5-15 ng/ml, which 
corresponds to  an  increase in antigen  receptor occupancy 
from  <1  to 45%  (37); these outcomes are (a)  ignorance at 
low concentrations; (b) surface Ig downregulation and par- 
tial inactivation of antigen-mediated signaling at intermedi- 
ate concentrations (4, 39); and (c) complete downregulation 
of surface  Ig accompanied by an  increase in  cell size and 
migration to the OP at the highest antigen concentrations. 
An alternative explanation for the positioning of B  cells 
in the follicle rather than the OP of the same line ofsHEL- 
Dbl-Tg mice  comes from  the work of Cyster et al., who 
performed  similar transfer  experiments  (9).  According  to 
their hypothesis, self-reactive B  cells are normally excluded 
from the follicle by a process of competition with the anti- 
foreign polyclonal B  cell repertoire. On the other hand, in 
sHEL-Dbl-Tg mice, the follicles are largely populated by B 
cells  with  the  same  single  specificity,  which  means  that 
newly generated  anti-HEL  B  cells can  enter  unimpeded. 
Although  follicular exclusion  is  a  plausible  concept  that 
may in theory play a role in shaping the B  cell repertoire as suggested by Cyster et al.  (9),  a number of aspects of the 
phenomenon need to be clarified before it can be regarded 
as proven. First,  no mechanism is currently available to ex- 
plain how it might operate.  Second,  it does not take into 
account  the  possibility raised here  that  the  persistence  of 
HEL-binding B cells after transfer into sHEL-Dbl-Tg mice, 
as  opposed  to  their  rapid  disappearance  from  sHEL-Tg 
mice, is a result of the difference in effective antigen con- 
centration  between  the  two  types  of recipients  (Fig.  6). 
Third, some of the data of Cyster et al. on competition be- 
tween  self-reactive (tolerant)  and anti-foreign  (normal)  B 
cells  in  mixed  chimeras  can be  explained by the  marked 
difference in the life span of the two populations of B cells. 
Finally, one prediction of the follicular exclusion model is 
that the survival ofanergic B cells from sHEL-Dbl-Tg mice 
transferred  into  similar  sHEL-Dbl-Tg  recipients  should 
vary depending on the size of the competing population of 
nor~tolerant  cells.  Survival  was  identical,  however,  when 
anergic cells were transferred into young recipients with al- 
most no competing cells or older recipients in which up to 
25% of B  cells  failed to bind HEL (Fulcher,  D.A.,  and A. 
Basten, manuscript in preparation). 
The decision as to whether a B  cell undergoes deletion 
or anergy is clearly related to the degree of cross-linking of 
Ig receptors on the B cell surface. On the other hand, none 
of the antigen-related or cellular factors described to date can 
fully explain what is responsible for the decision between acti- 
vation and tolerance. Since B cells, irrespective of their speci- 
ficity for self- or foreign antigen, can migrate to the OP on 
encounter with antigen, it is not unreasonable to suggest on a 
priori grounds that the purpose of doing so is to optimize the 
chance of interacting with T cells, and that a failure to receive 
T  cell help within a given time frame may result in death. 
The  capacity  of  activated  T  cells  from  anticytochrome 
TCR-Tg mice to rescue self-reactive B  cells  after transfer 
into  sHEL-Tg recipients as shown here is consistent with 
this hypothesis (Fig.  8).  Indeed in the presence of cognate 
T  cell help, self-reactive B cells not only survived and pro- 
liferated, but migrated out of the T  cell zone to form GC 
in follicles and proliferative foci in the red pulp despite the 
continued presence of self-antigen. At the same time, some 
of them secreted antibody while others populated the mar- 
ginal zone presumably as memory cells (data not shown). 
Many  previous  experiments  (41-45)  have  shown  that 
physical association ofT and B  cell epitopes is required for 
optimal T-B cell collaboration to take place in vivo. In the 
experimental system used here, T-B cell collaboration be- 
tween HEL-specific B cells and cytochrome-specific T  cells 
was observed after cytochrome peptide--pulsing the B  cells 
in vitro before adoptive transfer.  On the  other hand,  ad- 
ministration of cytochrome peptide in vivo was ineffective 
(Cook, M.C., M. Wikstrom, and B. Fazekas de St.  Groth, 
unpublished  observations),  thereby  confirming the  failure 
of "bystander" help to substitute for cognate help in vivo. 
Full T-B  cell collaboration was also  seen after immunisa- 
tion in vivo with a recombinant protein expressing linked 
HEL  and  cytochrome  epitopes  (Cook,  M.C.,  A.  Basten, 
and  B.  Fazekas de  St.  Groth,  manuscript in  preparation). 
Thus,  cytochrome peptide pulsing of HEL-specific B-cells 
in vitro, followed by antigen receptor engagement in vivo, 
generated a B  cell  phenotype that could be mimicked by 
administration of linked, but not unlinked,  HEL and cyto- 
chrome  epitopes in  vivo.  Presumably,  the  explanation  of 
this  phenomenon lies  in  the  ability of in vitro pulsing to 
achieve  relatively  higher  surface  levels  of peptide-MHC 
complexes. Consequently, the failure of unlinked T  and B 
cell epitopes to induce a significant T-B cell collaboration 
in vivo is caused by the inability of B cells to achieve suffi- 
cient levels of peptide-MHC complexes in the absence of 
either Ig-mediated endocytosis (46,  47)  or peptide pulsing 
in vitro. Consistent with this interpretation is our previous 
demonstration that at least 10,000-fold more antigen is re- 
quired by a polyclonal B cell population than by HEL-spe- 
cific  B  cells  to  induce  the  same  degree  of stimulation  of 
HEL-specific T  cells (40). 
A key role for T  cell help in determining the fate of anti- 
gen-stimulated B  cells is supported by two earlier observa- 
tions. First, provision ofT cell signals to tolerant B cells from 
sHEL-Dbl-Tg mice in the form of either CD40 ligand in 
vitro (39,  40) or HEL-primed T  cells with adjuvant in vivo 
(40)  was shown to result in complete reversal of tolerance 
despite the fact that these  cells had a partial  defect in  co- 
stimulatory function.  Second, B  cell tolerance in HEL-Tg 
mice was associated with a hyporesponsive T  cell compart- 
ment  caused by the  lower antigen  threshold  required  for 
induction ofT cell tolerance (12).  Thus, the primary deter- 
minant for induction  of B  cell tolerance in vivo may be a 
lack of T  cell help rather than an intrinsic ability of B  cells 
to be rendered tolerant upon exposure to self-antigen. Pro- 
vision of help via epitopes to which T  cells remain respon- 
sive could then lead to a breakdown in self tolerance and 
autoimmunity without any change in the intrinsic state of 
the B  cells.  The fact that such an event could well occur, 
e.g.,  during  coincidental infection,  points to  the  need for 
an  additional  T  independent  mechanism  of tolerance  in- 
duction capable of operating after initiation  of an autoim- 
mune  response.  Antigen-driven  B  cell  death  in  GC  re- 
ported  recently  by  several  groups  (48-50)  could  well 
provide such a mechanism by interfering with somatic hy- 
permutation and affinity maturation of B cells that have es- 
caped censoring in the OP. 
In summary, our current  findings,  when  taken in  con- 
junction  with previous data on B  cell lifespan (6-8), indi- 
cate that the  outcome  of the interaction between  antigen 
and B  cells  is largely determined by a combination of the 
degree of Ig receptor engagement and availability of T  cell 
help. The stronger the self-antigen signal, the shorter the B 
cell life span and the less likely they are to be stimulated by 
T  cell help  (30),  a conclusion also  supported by recent in 
vitro experiments with anti-Ig reagents (51).  On the other 
hand, the fact that self-reactive B cells can be rescued by T 
cell signals  after migration into the OP provides a plausible 
explanation for the occurrence of autoantibody-dependent 
autoimmunity when B  cells encounter antigen with self-B 
cell and foreign T  cell determinants (30,  52, 53). 
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